Actuate Therapeutics Operating Income

Actuate Therapeutics (ACTU) currently reports a operating income of $-22M as of March 2026. That compares with $-24M in the prior-year period — up 8.1% year over year. Use the charts on this page to explore Actuate Therapeutics's operating income history and peer comparisons.

Actuate Therapeutics's operating income increased from $-24M to $-22M — a 8.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Actuate Therapeutics reported $-22M in operating income as of March 2026. That compares with $-24M in the prior-year period — up 8.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-22M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Actuate Therapeutics, and consider following ACTU for alerts when major investors trade the stock.